Dr. Guy Chamberland returns to “Stock Day” Podcast with Everett Jolly to discuss Tetra-Biopharma
May 09, 2018 08:30 ET
|
Tetra Bio-Pharma
PHOENIX, May 09, 2018 (GLOBE NEWSWIRE) -- Dr. Guy Chamberland, Co-Founder, Chief Scientific Officer and Interim-CEO of Tetra-Biopharma Inc. (OTCQB:TBPMF) (TSX-V:TBP) (“the Company”) joined Everett...
Nemus Bioscience Adds to Senior Leadership Team
May 07, 2018 08:30 ET
|
Nemus Bioscience, Inc.
LONG BEACH, CA, May 07, 2018 (GLOBE NEWSWIRE) -- Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially...
CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production
May 01, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced it received an investment of $500,000 from a...
Kannalife Sciences CEO Dean Petkanas to Provide Presentation on Industry Advancement at 2018 Cannabinoids in Medicine Summit
April 27, 2018 10:00 ET
|
Kannalife Sciences, Inc.
NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc. (“Kannalife”), a phyto-medical company, announced today that the Company’s CEO Dean Petkanas will be presenting at the 2018...
AXIM Biotech Secures Additional Funding to Advance Cannabidnoid-Based Clinical Development Program for Multiple Indications
April 23, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company has secured...
AXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal Activities
April 18, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent...
LiveWire Ergogenics Purchases Two Self-Contained Cloning Pods to Add to its Coachella Cultivation and Nursery Operation
April 12, 2018 09:00 ET
|
LiveWire Ergogenics, Inc
Anaheim, CA, April 12, 2018 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC: LVVV), a company focused on the acquisition and licensing of special purpose real estate properties and management of...
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
April 04, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE...
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea
April 03, 2018 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that it has...
Lexaria Biosciences Engages CFN Media to Broaden Investor Awareness -- CFN Media
March 28, 2018 08:30 ET
|
CFN Media
SEATTLE, March 28, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced that...